Welcome to LookChem.com Sign In|Join Free
  • or
Boc-L-Lys(Cbz)-L-Leu-OH is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

88991-01-9

Post Buying Request

88991-01-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

88991-01-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 88991-01-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,8,9,9 and 1 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 88991-01:
(7*8)+(6*8)+(5*9)+(4*9)+(3*1)+(2*0)+(1*1)=189
189 % 10 = 9
So 88991-01-9 is a valid CAS Registry Number.

88991-01-9Relevant academic research and scientific papers

Design, SAR, angiogenic activities evaluation and pro-angiogenic mechanism of new marine cyclopeptide analogs

Li,Lu,Wu,Yu,Xu,Qiu,Pei,Lin,Pang

, p. 1183 - 1194 (2013/07/28)

Angiogenesis plays an important role in a wide range of physiological processes. In this paper, we designed and synthesized a series of new analogs including 11 line-peptides and 9 cyclo-peptides by using a marine cyclopeptide (compound 21) which could st

Design and synthesis of Hsp90 inhibitors: Exploring the SAR of Sansalvamide A derivatives

Sellers, Robert P.,Alexander, Leslie D.,Johnson, Victoria A.,Lin, Chun-Chieh,Savage, Jeremiah,Corral, Ricardo,Moss, Jason,Slugocki, Tim S.,Singh, Erinprit K.,Davis, Melinda R.,Ravula, Suchitra,Spicer, Jamie E.,Oelrich, Jenna L.,Thornquist, Andrea,Pan, Chung-Mao,McAlpine, Shelli R.

experimental part, p. 6822 - 6856 (2010/10/18)

Utilizing the structure-activity relationship we have developed during the synthesis of the first two generations and mechanism of action studies that point to the interaction of these molecules with the key oncogenic protein Hsp90, we report here the design of 32 new Sansalvamide A derivatives and their synthesis. Our new structures, designed from previously reported potent compounds, were tested for cytotoxicity on the HCT116 colon cancer cell line, and their binding to the biological target was analyzed using computational studies involving blind docking of derivatives using Autodock. Further, we show new evidence that our molecules bind directly to Hsp90 and modulate Hsp90's binding with client proteins. Finally, we demonstrate that we have integrated good ADME properties into a new derivative.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 88991-01-9